... a hedged play on Novo Nordisk (NVO) MarketIntelligenceCenter.com’s patented trade-picking algorithms selected a Jun 15, 2018 $50 covered call for a net debit in the $48.17 area. That is also the break-even stock price for the covered call. …
Mr. Jeppe Christiansen has been Vice Chairman of the Board of Directors of Novo Nordisk A/S since March 20, 2013. He is Chairman of the Remuneration Committee of the Company. He has been Chief Executive Officer of …
Shares of Novo Nordisk NVO have surged 55.4% in the past year, outperforming the 18% increase registered by the industry. Here we analyze the factors that led to the rally. Last year has been quite eventful for the company as it …
From an investment attractiveness viewpoint, NVO is ranked in the top decile of the sector with a ranking of 28 among the 782 companies in the sector; the stock's current Portfolio Grader score places it 2 among the 132 companies in this …
Novo Nordisk NVO is a global healthcare company and a leader in the worldwide diabetes market. Also, the company is a key player in hemophilia care, growth hormone therapy, hormone replacement therapy and obesity. However, let’s find …
NVO's market value is $99.9 billion which falls in the top decile in its industry group. The stock's current Portfolio Grader score places it 4 among the 133 companies in this industry group, putting it in the top decile; among the sector leaders …